Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LABELLO II: single-shot ropivacaine levels after total knee replacement
NL-OMON22415Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine and epinephrine in osteoarthritis (OA), sponsored by Haaglanden Medical Centre. Primary endpoints: Total ropivacaine levels in shed blood, Unbound ropivacaine levels in shed blood and 2 more. Started Jan 2011; status: active, not recruiting.
02
Drugs
ropivacaineepinephrine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON22415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22415.